164 related articles for article (PubMed ID: 32283496)
1. Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.
Hanna GJ; Bae JE; Lorch JH; Schoenfeld JD; Margalit DN; Tishler RB; Haddad RI; Chau NG
Oral Oncol; 2020 Jul; 106():104690. PubMed ID: 32283496
[TBL] [Abstract][Full Text] [Related]
2. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
[TBL] [Abstract][Full Text] [Related]
3. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection.
Oplatek A; Ozer E; Agrawal A; Bapna S; Schuller DE
Laryngoscope; 2010 Jan; 120(1):65-70. PubMed ID: 19877226
[TBL] [Abstract][Full Text] [Related]
4. Management of adenoid cystic carcinoma of the head and neck: a single-institute study with over 25-year follow-up.
Ishida E; Ogawa T; Rokugo M; Ishikawa T; Wakamori S; Ohkoshi A; Usubuchi H; Higashi K; Ishii R; Nakanome A; Katori Y
Head Face Med; 2020 Jul; 16(1):14. PubMed ID: 32616049
[TBL] [Abstract][Full Text] [Related]
5. Dominant cell type analysis predicts head and neck adenoid cystic carcinoma outcomes.
Xuan L; Yuan J; Zhang H; Zhang Y; Liu H
Ann Diagn Pathol; 2022 Feb; 56():151867. PubMed ID: 34826781
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.
Lorini L; Ardighieri L; Bozzola A; Romani C; Bignotti E; Buglione M; Guerini A; Lombardi D; Deganello A; Tomasoni M; Bonini SA; Sigala S; Farina D; Ravanelli M; Bossi P
Oral Oncol; 2021 Apr; 115():105213. PubMed ID: 33578204
[TBL] [Abstract][Full Text] [Related]
7. [The clinicopathological features and curative effect of the bronchoscopic interventional therapy combined with radiotherapy for the treatment of locally recurrent lung adenoid cystic carcinoma].
Zhu DC; Xu JH; Zhang MH; Zhu HX; Zhang Y; Zhang T; Xu GR
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):864-868. PubMed ID: 30481940
[No Abstract] [Full Text] [Related]
8. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
[TBL] [Abstract][Full Text] [Related]
9. Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma.
Xu MJ; Wu TJ; van Zante A; El-Sayed IH; Algazi AP; Ryan WR; Ha PK; Yom SS
J Otolaryngol Head Neck Surg; 2018 Apr; 47(1):28. PubMed ID: 29695289
[TBL] [Abstract][Full Text] [Related]
10. Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N; Fujiwara Y; Wang X; Ohmoto A; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Takahashi S
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3037-3043. PubMed ID: 33219858
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck.
Naito T; Noji R; Kugimoto T; Kuroshima T; Tomioka H; Fujiwara S; Suenaga M; Harada H; Kano Y
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138214
[No Abstract] [Full Text] [Related]
12. Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.
Tchekmedyian V; Sherman EJ; Dunn L; Tran C; Baxi S; Katabi N; Antonescu CR; Ostrovnaya I; Haque SS; Pfister DG; Ho AL
J Clin Oncol; 2019 Jun; 37(18):1529-1537. PubMed ID: 30939095
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.
Jang S; Patel PN; Kimple RJ; McCulloch TM
Anticancer Res; 2017 Jun; 37(6):3045-3052. PubMed ID: 28551643
[TBL] [Abstract][Full Text] [Related]
14. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
[TBL] [Abstract][Full Text] [Related]
15. [Survival Analysis of 76 Cases of Head and Neck Adenoid Cystic Carcinoma
with Lung Metastasis].
Yu Z; Yu L; Chen X; Yang X; Zhang B; Yu T; Du X
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):412-419. PubMed ID: 34157801
[TBL] [Abstract][Full Text] [Related]
16. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
[TBL] [Abstract][Full Text] [Related]
17. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
Xie M; Wei S; Wu X; Li X; You Y; He C
Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
[TBL] [Abstract][Full Text] [Related]
18. [Adenoid cystic carcinoma of the head and neck--a clinical study of 27 cases].
Nishioka H; Majima Y; Yamagiwa M; Ukai K; Sakakura Y
Gan No Rinsho; 1986 Jul; 32(8):861-7. PubMed ID: 3018315
[TBL] [Abstract][Full Text] [Related]
19. Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.
Hämetoja H; Hirvonen K; Hagström J; Leivo I; Saarilahti K; Apajalahti S; Haglund C; Mäkitie A; Bäck L
Virchows Arch; 2017 Dec; 471(6):785-792. PubMed ID: 28600602
[TBL] [Abstract][Full Text] [Related]
20. Expression of Submaxillary Gland Androgen-regulated Protein 3A (SMR3A) in Adenoid Cystic Carcinoma of the Head and Neck.
Thierauf J; Veit JA; Grünow J; Döscher J; Weißinger S; Whiteside T; Beutner D; Quaas A; Plinkert P; Hoffmann TK; Hess J
Anticancer Res; 2016 Feb; 36(2):611-5. PubMed ID: 26851015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
